| 000 | 01787 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515013004.0 | ||
| 264 | 0 | _c20060310 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a1359-4117 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGao, Xiaohua | |
| 245 | 0 | 0 |
_aCurcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. _h[electronic resource] |
| 260 |
_bJournal of experimental therapeutics & oncology _c2005 |
||
| 300 |
_a39-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBrain Neoplasms _xpathology |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 | _aCaspase 9 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCurcumin |
| 650 | 0 | 4 |
_aCytochromes c _xmetabolism |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aGlioma _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aDeeb, Dorrah | |
| 700 | 1 | _aJiang, Hao | |
| 700 | 1 | _aLiu, Yong B | |
| 700 | 1 | _aDulchavsky, Scott A | |
| 700 | 1 | _aGautam, Subhash C | |
| 773 | 0 |
_tJournal of experimental therapeutics & oncology _gvol. 5 _gno. 1 _gp. 39-48 |
|
| 999 |
_c16032874 _d16032874 |
||